Sumacef en es it fr

Sumacef Brand names, Sumacef Analogs

Sumacef Brand Names Mixture

  • None

Sumacef Chemical_Formula


Sumacef RX_link

Sumacef fda sheet

Sumacef msds (material safety sheet)

Sumacef Synthesis Reference

L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)

Sumacef Molecular Weight

363.389 g/mol

Sumacef Melting Point


Sumacef H2O Solubility

1110 mg/L

Sumacef State


Sumacef LogP


Sumacef Dosage Forms

Capsule; Tablet; Oral liquid

Sumacef Indication

For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes

Sumacef Pharmacology

Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.

Sumacef Absorption

Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.

Sumacef side effects and Toxicity

Nausea, vomiting, diarrhoea, allergic rashes may occur

Sumacef Patient Information

Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.

Sumacef Organisms Affected

Enteric bacteria and other eubacteria